Winthrop Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $845K | Buy |
4,555
+1,450
| +47% | +$269K | 0.08% | 74 |
|
|
2025
Q1 | $651K | Sell |
3,105
-1,389
| -31% | -$291K | 0.08% | 74 |
|
|
2024
Q4 | $799K | Buy |
4,494
+1,149
| +34% | +$204K | 0.1% | 69 |
|
|
2024
Q3 | $661K | Sell |
3,345
-67
| -2% | -$13.2K | 0.08% | 73 |
|
|
2024
Q2 | $585K | Sell |
3,412
-170
| -5% | -$29.2K | 0.08% | 73 |
|
|
2024
Q1 | $652K | Buy |
3,582
+78
| +2% | +$14.2K | 0.09% | 67 |
|
|
2023
Q4 | $543K | Sell |
3,504
-58
| -2% | -$8.99K | 0.08% | 72 |
|
|
2023
Q3 | $531K | Buy |
3,562
+124
| +4% | +$18.5K | 0.09% | 67 |
|
|
2023
Q2 | $463K | Buy |
3,438
+26
| +0.8% | +$3.5K | 0.07% | 78 |
|
|
2023
Q1 | $544K | Buy |
3,412
+9
| +0.3% | +$1.43K | 0.1% | 68 |
|
|
2022
Q4 | $550K | Sell |
3,403
-1,041
| -23% | -$168K | 0.1% | 67 |
|
|
2022
Q3 | $596K | Buy |
4,444
+1
| +0% | +$134 | 0.13% | 56 |
|
|
2022
Q2 | $680K | Buy |
4,443
+1
| +0% | +$153 | 0.16% | 50 |
|
|
2022
Q1 | $720K | Buy |
4,442
+502
| +13% | +$81.4K | 0.15% | 53 |
|
|
2021
Q4 | $533K | Buy |
3,940
+11
| +0.3% | +$1.49K | 0.11% | 65 |
|
|
2021
Q3 | $424K | Buy |
3,929
+1,804
| +85% | +$195K | 0.09% | 65 |
|
|
2021
Q2 | $239K | Sell |
2,125
-18
| -0.8% | -$2.02K | 0.05% | 113 |
|
|
2021
Q1 | $232K | Buy |
2,143
+16
| +0.8% | +$1.73K | 0.06% | 116 |
|
|
2020
Q4 | $228K | Buy |
+2,127
| New | +$228K | 0.06% | 112 |
|